GENEVA, July 1 -- NEURONASAL, INC. filed a patent application (US2025/059398) for “TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES WITH N-ACETYLCYSTEINE AND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS”. With publication no. WO/2026/128812, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/198

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....